Misoprostol administered sublingually at a dose of 12.5 μg versus vaginally at a dose of 25 μg for the induction of full-term labor: a randomized controlled trial

Table 4 Indications for Caesarean section following labor induction according to the route of administration of misoprostol

Indications for Caesarean Section	Sublingual misoprostol (n = 98)		Vaginal misoprostol (n = 100)		RR	95% CI	P-value
Indications for Caesarean Section	n	%	n	%	RR	95% CI	P-value
Failed induction	34	34.7	23	23.0	1.31	0.99–1.74	0.07**
Labor dystocia	9	9.2	4	4.0	1.44	0.97–2.13	0.14**
Non-reassuring fetal heart rate	3	3.1	6	6.0	0.66	0.26–1.69	0.51*
Cephalopelvic disproportion	3	3.1	9	9.0	0.49	0.18–0.32	0.08**
Persistent hypertonus/hypersystole	1	1	2	2.0	0.67	0.13–3.36	1.00*
Persistent tachysystole	0	0	2	2.0	0	_____	0.51*
Others	8	8.2	11	11.0	0.84	0.48–1.45	0.49**

RR Relative risk, CI Confidence interval, n: sample, %: percentage. * Fisher’s exact test; ** Chi-square test

ISSN: 1742-4755